The worldwide burden of postpartum haemorrhage: Policy development where inaction is lethal

International Journal of Gynecology and Obstetrics

Volumn 94, Issue SUPPL. 2, 2006, Pages

  Potts, Malcolm ^a   Hemmerling, Anke ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERGOMETRINE; ERGOT ALKALOID; MIFEPRISTONE; MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN DERIVATIVE; UTEROTONIC AGENT;

ABORTION; ARTICLE; CHILDBIRTH; CLINICAL TRIAL; DEVELOPING COUNTRY; DIARRHEA; EVIDENCE BASED MEDICINE; FEVER; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH PRACTITIONER; HEALTH SERVICE; HEART MUSCLE ISCHEMIA; HUMAN; MATERNAL MORTALITY; POSTPARTUM HEMORRHAGE; PREGNANCY; PRIORITY JOURNAL; SHIVERING; TERATOGENICITY; THERAPEUTIC ABORTION; UTERUS RUPTURE;

EID: 33845212720     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(06)60003-9     Document Type: Article

References (53)

1. AbouZahr C, Wardlaw T. Maternal mortality at the end of the decade: what signs of progress? Bulletin of the World Health Organization, Vol. 79, No. 6, 2001 pp. 561-73
2. World Health Organization, Geneva, 1996. Revised 1990 Estimates of Maternal Mortality: A New Approach by WHO and UNICEF.
3. AbouZahr C, Wardlaw T. WHO, UNICEF and UNFPA, Maternal Mortality in 2000: Estimates Developed by WHO, UNICEF and UNFPA. Geneva, 2004.
4. Hogberg U., and Wall S. Secular trends in maternal mortality in Sweden from 1750 to 1980. Bull World Health Organ 64 1 (1986) 79-84
5. Loudon I. Maternal mortality: 1880-1950. Some regional and international comparisons. Soc Hist Med 1 2 (1988 Aug) 183-228
6. Callaghan W., and Berg C. Maternal mortality surveillance in the United States: moving into the twenty-first century. J Am Med Womens Assoc 57 3 (2002 Summer) 131-134 139.
7. Irvine L. Maternal mortality in the past and its relevance to developing countries today. American Journal of Clinical Nutrition 72 1 (July 2000) 241S-246s
8. Hogberg U., Wall S., and Brostrom G. The impact of early medical technology on maternal mortality in late 19th century Sweden. Int J Gynaecol Obstet 24 4 (1986 Aug) 251-256
9. Safe Motherhood Fact Sheets (1998) Safe Motherhood Initiative. English. http://www.safemotherhood.org/re-sources/pdf/e_tech_facts.pdf
10. WHO, UNICEF and UNFPA, Maternal Mortality in 2000: Estimates Developed by WHO, UNICEF and UNFPA. Geneva, 2004.
11. AbouZahr C, Wardlaw T. Maternal Mortality in 2000: Estimates Developed by WHO, UNICEF and UNFPA. Geneva, 2004.
12. Prata N., Montagu D., and Jefferys E. Private sector, human resources and health franchising in Africa. Bull World Health Organ 83 4 (2005 Apr) 274-279 Epub 2005 Apr
13. McCord C., and Chowdhury Q. A cost-effect small hospital in Bangaldesh: what it can mean for emergency obstetric care. Int J Obstet Gynecol 81 (2003) 83-92
14. The Lancet. Poaching nurses from the developing world. Lancet 367 (2006) 1791-1792
15. Khan K., Wojdyla D., Say L., Gulmezoglu A., and Van Look P. WHO analysis of causes of maternal death: a systematic review. Lancet 367 9516 (2006 Apr 1) 1066-1074
16. Boyd J., and Hamilton W. The Human Placenta (1997), Heffer and Sons Ltd., Cambridge
17. Mossman H. Vertebrate Fetal Membranes: Compartive Ontology and Morphology, Evolution, Phylogenic Significance, Basic Functions, Research Opportunities (1987), Rutgers University Press, New Brunswick
18. Potts M. Implantation. PhD Thesis, Cambridge University.
19. Potts M. The attachment phase of ovoimplantation. Am J Obstet Gynecol 96 8 (1966 Dec 15) 1122-1128
20. Wildman D., Chen C., Erez O., Grossman L., Goodman M., and Romero R. Evoution of the mammalian placenta revealed by phyogentic analysis. Proceedings National Academy of Sciences 103 (2006) 3203-3208
21. Moir J. The Obstetrician bids, and the uterus contracts. Brit Med J 5416 (1964) 1025-1029
22. van Dongen P. History of ergot alkaloids from ergotism to ergometrine. Eur J Obstet Gynecol Reprod Biol 60 2 (1995 Jun) 109-116
23. Bond G., and Van Zee A. Overdosage of misoprostol in pregnancy. Am J Obstet Gynecol 171 2 (1994 Aug) 561-562
24. Graber D., and Meier K. Acute misoprostol toxicity. Ann Emerg Med 20 5 (1991 May) 549-551
25. Bentov Y., Sheiner E., and Katz M. Misoprostol overdose during the first trimester of pregnancy. Eur J Obstet Gynecol Re-prod Biol 115 1 (2004 Jul 15) 108-109
26. Austin J., Ford M., Rouse A., and Hanna E. Acute intravaginal misoprostol toxicity with fetal demise. J Emerg Med 15 1 (1997 Jan-Feb) 61-64
27. Chong Y., Chua S., and Arulkumaran S. Severe hyperthermia following oral misoprostol in the immediate postpartum period. Obstet Gynecol 90 4 Pt 2 (1997 Oct) 703-704
28. Kotsonis F., Dodd D., Regnier B., and Kohn F. Preclinical toxicology profile of misoprostol. Dig Dis Sci 30 11 Suppl (1985 Nov) 142S-146S
29. Pottie K. Is misoprostol teratogenic? Misoprostol use during early pregnancy and its association with Mobius' syndrome. Can Fam Physician 45 (1999 Feb) 315-316
30. Gonzalez C., Marques-Dias M., Kim C., Sugayama S., Da Paz J., Huson S., and Holmes L. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. The Lancet 351 9116 (1998 May 30) 1624-1627
31. Shepard T. Mobius syndrome after misoprostol: a possible teratogenic mechanism. Lancet 346 8977 (1995 Sep 16) 780
32. Sanchez O., and Guerra D. Moebius syndrome due to the use of misoprostol. Case report. Invest Clin 44 2 (2003 Jun) 147-153
33. Schuler L., Pastuszak A., Sanseverino T., et al. Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study. Reprod Toxicol 13 2 (1999 Mar-Apr) 147-151
34. Vargas F., Schuler-Faccini L., and Brunoni D. Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet 95 4 (2000 Dec 11) 302-306
35. Orioli I., and Castilla E. Epidemiological assessment of misoprostol teratogenicity. BJOG 107 4 (2000 Apr) 519-523
36. Miller S., Lehman T., Campbell M., Hemmerling A., Brito S., Rodriguez H., Gonzalez W., Cordero M., and Calderon V. /Misoprostol and declining abortio-related morbidity in Santo Domingo, Dominican Republci: a temporal association. Int J Obstet Gynaecol 112 (2005) 1-6
37. Gulmezoglu A., Villar J., Ngoc N., et al. (WHO Collaborative Group To Evaluate Misoprostol in the Management of the Third Stage of Labour). WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 358 9283 (2001 Sep 1) 689-695
38. Prata N, Gypson R, Hamza S, Nada K, Vahidnia F, Potts M, Campbell M. Misoprostol and active management of third stage of labor. Int J Gynaecol Obstet, In press.
39. The Family Health Survey, 2004, League of Arab states, Pan Arab Project For Family Health PAPFAM. Yemen Arab Republic.
40. Reproductive Health Support Programme Yemen, 2005, Formulation Mission. Terms of references.
41. Banks J., Marmot M., Oldfield Z., and Smith J. Disease and disadvantage in the United States and in England. JAMA 295 17 (2006 May 3) 2037-2045
42. Bergström S., and Goodburn E. The role of traditional birth attendants in the reduction of maternal mortality. Studies in Health Services Organisation and Policy 17 (2001) 1-450 In: De Brouwere V, Van Lerberghe W, eds. Safe Motherhood Strategies: A Review of the Evidence.
43. Goodburn E., et al. Training traditional birth attendants in clean delivery does not prevent postpartum infection. Health Policy and Planning 15 4 (2000) 394-399
44. Kamal I. The traditional birth attendant: a reality and a challenge. Int J Gynecol Obstet 63 Suppl.1 (1998) S43-S52
45. Miller S, Hamza S, Bray EH, Lester F, Nada K, Gibson R, Fathalla M, Mourad M, Fathy A, Turan JM, Dau KQ, Nasshar I, Elshair I, Hensleigh P. First aid for obstetric haemorrhage: the pilot study of the non-pneumatic anti-shock garment in Egypt.
46. AbouZahr C., and Wardlaw T. Maternal mortality at the end of the decade: what signs of progress?. Bulletin of the World Health Organization Vol. 79 6 (2001) 561-573
47. World Health Organization. Midwifery education: action for safe Motherhood, report of a Collaborative Pre-Congress Workshop. In: WHO, editor. Geneva, 1990.
48. Prata N., Montagu D., and Jefferys E. Private sector, human resources and health franchising in Africa. Bull World Health Organ 83 4 (2005 Apr) 274-279 Epub 2005 Apr.
49. Reproductive Health Support Programme Yemen, 2005, Formulation Mission. Terms of references.
50. Sanghvi H, Pfitzer A (eds). Preventing Postpartum Hemorrhage. From Research to Practice. Workshop Report. JHPIEGO. Baltimore. http://www.jhpiego.org/resources/pubs/mnh/PPHwkshprpt.pdf
51. Keriakos R., and Mukhopadhyay A. The use of the Rusch balloon for management of severe postpartum haemorrhage. J Obstet Gynaecol 26 4 (2006 May) 335-338
52. Alan Guttmacher Institute. Sharing Responsibility: Women, Society & Abortion Worldwide (1999), The Institute, New York 37
53. Mukherjee S., and Bhose L. Induction of labor and abortion with quinine infusion in intrauterine fetal deaths. Am J Obstet Gynecol 101 6 (1968 Jul 15) 853-854